BioNxt Solutions Inc. (FRA:BXT)
0.3540
+0.0260 (7.93%)
At close: Jun 27, 2025, 10:00 PM CET
BioNxt Solutions Statistics
Total Valuation
FRA:BXT has a market cap or net worth of EUR 42.89 million. The enterprise value is 46.40 million.
Market Cap | 42.89M |
Enterprise Value | 46.40M |
Important Dates
The last earnings date was Monday, June 2, 2025.
Earnings Date | Jun 2, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 116.53M |
Shares Outstanding | n/a |
Shares Change (YoY) | +14.30% |
Shares Change (QoQ) | +2.98% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 110.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,915.79 |
PB Ratio | -8.81 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -12.62 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
Current Ratio | 0.15 |
Quick Ratio | 0.11 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.87 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -342.44% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 145.24% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -57,796 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.35% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +67.35% |
50-Day Moving Average | 0.33 |
200-Day Moving Average | 0.27 |
Relative Strength Index (RSI) | 53.09 |
Average Volume (20 Days) | 20,327 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:BXT had revenue of EUR 14,708 and -3.68 million in losses. Loss per share was -0.04.
Revenue | 14,708 |
Gross Profit | 14,708 |
Operating Income | -3.18M |
Pretax Income | -3.73M |
Net Income | -3.68M |
EBITDA | -3.12M |
EBIT | -3.18M |
Loss Per Share | -0.04 |
Balance Sheet
The company has 211,861 in cash and 4.30 million in debt, giving a net cash position of -4.09 million.
Cash & Cash Equivalents | 211,861 |
Total Debt | 4.30M |
Net Cash | -4.09M |
Net Cash Per Share | n/a |
Equity (Book Value) | -4.87M |
Book Value Per Share | -0.04 |
Working Capital | -2.41M |
Cash Flow
Operating Cash Flow | -2.16M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -21,642.20% |
Pretax Margin | -25,392.08% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FRA:BXT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.30% |
Shareholder Yield | n/a |
Earnings Yield | -8.57% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |